CELSO
ARANGO LÓPEZ
Catedrático de universidad
KU Leuven
Lovaina, BélgicaPublicaciones en colaboración con investigadores/as de KU Leuven (23)
2023
-
Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults
Journal of Affective Disorders, Vol. 326, pp. 249-261
2022
-
A normative chart for cognitive development in a genetically selected population
Neuropsychopharmacology, Vol. 47, Núm. 7, pp. 1379-1386
-
Ethical considerations for precision psychiatry: A roadmap for research and clinical practice
European Neuropsychopharmacology, Vol. 63, pp. 17-34
-
Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A)
Journal of Affective Disorders, Vol. 299, pp. 367-376
-
The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic
Journal of Affective Disorders, Vol. 299, pp. 393-407
2021
-
Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion
Molecular Psychiatry, Vol. 26, Núm. 8, pp. 4496-4510
-
Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: A Delphi expert consensus study
European psychiatry : the journal of the Association of European Psychiatrists, Vol. 64, Núm. 1, pp. e7
-
Reconceptualising treatment-resistant depression as difficult-to-treat depression
The Lancet Psychiatry
2020
-
De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia
Nature Neuroscience, Vol. 23, Núm. 2, pp. 179-184
-
The identification, assessment and management of difficult-to-treat depression: An international consensus statement
Journal of Affective Disorders, Vol. 267, pp. 264-282
-
Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome
Nature Medicine, Vol. 26, Núm. 12, pp. 1912-1918
2018
-
Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder
PLoS ONE, Vol. 13, Núm. 12
-
Understanding the pediatric psychiatric phenotype of 22q11.2 deletion syndrome
American Journal of Medical Genetics, Part A, Vol. 176, Núm. 10, pp. 2182-2191
-
Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjects
American Journal of Medical Genetics, Part A, Vol. 176, Núm. 10, pp. 2172-2181
2016
-
Type 2 diabetes mellitus in youth exposed to antipsychotics: A systematic review and meta-analysis
JAMA Psychiatry, Vol. 73, Núm. 3, pp. 247-259
2015
-
Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome
JAMA Psychiatry, Vol. 72, Núm. 4, pp. 377-385
2014
-
Common variant at 16p11.2 conferring risk of psychosis
Molecular Psychiatry, Vol. 19, Núm. 1, pp. 108-114
-
Identifying gene-environment interactions in schizophrenia: Contemporary challenges for integrated, large-scale investigations
Schizophrenia Bulletin, Vol. 40, Núm. 4, pp. 729-736
-
Paediatric European Risperidone Studies (PERS): context, rationale, objectives, strategy, and challenges
European Child and Adolescent Psychiatry, Vol. 23, Núm. 12, pp. 1149-1160
2011
-
Common variants at VRK2 and TCF4 conferring risk of schizophrenia
Human Molecular Genetics, Vol. 20, Núm. 20, pp. 4076-4081